3Sato A,Narukawa M.Investigation of the relationship between a starting dose in first-in-human studies and no observed adverse effect level in nonclinical studies[J].Int J Clin Pharmacol Ther,2014,52(9):770.
4Harrak M,Khabbal Y,Amarti A,et al.Pharmacogenetics and prediction of side effects of drugs[J].Ann Biol Clin(Paris),2014,72(4):405.
